Michael J. Valentino, President & CEO at Adams Respiratory Therapeutics, Inc. (ARXT), sold 11,401 shares at $35.76 ($409K) on 2006-10-02, disclosed to the SEC on 2006-10-04.
Scheduled sale ($409k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.62 | 300 | $11K | 2.6% |
| 2 | $35.64 | 200 | $7K | 1.7% |
| 3 | $35.65 | 200 | $7K | 1.7% |
| 4 | $35.66 | 100 | $4K | 0.9% |
| 5 | $35.67 | 100 | $4K | 0.9% |
| 6 | $35.68 | 100 |
| $4K |
| 0.9% |
| 7 | $35.70 | 500 | $18K | 4.4% |
| 8 | $35.71 | 700 | $25K | 6.1% |
| 9 | $35.73 | 200 | $7K | 1.7% |
| 10 | $35.74 | 300 | $11K | 2.6% |
| 11 | $35.75 | 600 | $21K | 5.2% |
| 12 | $35.76 | 400 | $14K | 3.5% |
| 13 | $35.78 | 1,620 | $58K | 14.2% |
| 14 | $35.79 | 100 | $4K | 0.9% |
| 15 | $35.80 | 400 | $14K | 3.5% |
| 16 | $35.82 | 700 | $25K | 6.1% |
| 17 | $35.84 | 182 | $7K | 1.6% |
| 18 | $36.00 | 1,300 | $47K | 11.4% |
| 19 | $36.02 | 700 | $25K | 6.2% |
| 20 | $36.12 | 345 | $12K | 3.0% |
| 21 | $36.14 | 198 | $7K | 1.7% |
| 22 | $36.15 | 200 | $7K | 1.8% |
| 23 | $36.16 | 298 | $11K | 2.6% |
| 24 | $36.17 | 859 | $31K | 7.6% |
| 25 | $36.18 | 100 | $4K | 0.9% |
| 26 | $36.19 | 100 | $4K | 0.9% |
| 27 | $36.21 | 200 | $7K | 1.8% |
| 28 | $36.22 | 100 | $4K | 0.9% |
| 29 | $36.24 | 200 | $7K | 1.8% |
| 30 | $36.25 | 99 | $4K | 0.9% |
| Total | $35.89 avg | 11,401 | $409K | 100% |
| Filing → |
| PLXP | BUY | 2020-11-20 | $1.0M | — | Filing → |
| PLXP | BUY | 2019-05-21 | $497K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $400K | — | Filing → |